FIXIUM CL – Cefixime 200 mg.+ Potassium Clavulanate 125 mg
Description
Cefixime & Potassium Clavulanate Tablets combine Cefixime, a third-generation cephalosporin antibiotic, with Potassium Clavulanate, a beta-lactamase inhibitor, to provide broad-spectrum antibacterial protection. This potent combination is effective in treating a wide range of bacterial infections of the respiratory tract, urinary tract, ear, throat, and skin. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to bacterial death, while Clavulanic acid prevents bacterial enzymes (beta-lactamases) from inactivating Cefixime, thereby extending its antibacterial spectrum. Together, they deliver enhanced efficacy even against resistant bacterial strains, ensuring faster recovery and reduced recurrence.
Key Benefits:
✅Broadened Antibacterial Spectrum: Combines a cephalosporin with a beta-lactamase inhibitor to effectively combat resistant pathogens.
✅Enhanced Clinical Efficacy: Clavulanate boosts Cefixime’s action by neutralizing bacterial resistance mechanisms.
✅Reliable for Mixed Infections: Provides comprehensive coverage where infections involve multiple bacterial strains.
Targeted Specialties:
✅Infectious Disease Specialists
✅General Medicine
✅Pulmonology
✅ENT (Otorhinolaryngology)
✅Pediatrics
Disclaimer: To be administered only under the supervision of a qualified healthcare professional. Intended for use by registered medical practitioners. Not for public promotion











